Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Therapy (Telmisartan/Amlodipine/Rosuvastatin) in Dyslipidemia and Hypertension
NCT03088254Phase 3Completed
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Start
- Sep 2016
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, amlodipine, rosuvastatin in dyslipidemia, hypertension (HTN), sponsored by Jeil Pharmaceutical Co., Ltd.. Started Sep 2016; status: completed.
02
Drugs
telmisartanamlodipinerosuvastatin
03
Conditions
dyslipidemiahypertension (HTN)
Beyond the preview
Go deeper on NCT03088254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03088254.